v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Net sales $ 3,114 $ 2,951
Cost of goods sold 1,312 1,569
Gross profit 1,802 1,382
Sales and marketing 1,480 995
General and administrative 4,091 3,721
Research and development 1,973 871
Litigation costs, net 606 2,572
Total operating expenses 8,150 8,159
Loss from continuing operations (6,348) (6,777)
Interest (income) expense, net 108 (184)
Loss (gain) on revaluation of warrant liability 1,655 (5,187)
Other (income) expense, net (71) 105
Loss from continuing operations before provision for income taxes (7,824) (1,879)
Income tax expense 70 8
Net loss from continuing operations (7,894) (1,887)
Income (loss) from discontinued operations 425 (2,046)
Net loss (7,469) (3,933)
Less: dilutive gain on revaluation of warrant liability   (5,201)
Net loss for dilutive earnings per share $ (7,469) $ (9,134)
Net loss from continuing operations per share - basic (in dollars per share) $ (0.18) $ (0.05)
Net loss from continuing operations per share - diluted (in dollars per share) (0.18) (0.17)
Net income (loss) from discontinued operations per share - basic (in dollars per share) 0.01 (0.05)
Net income (loss) from discontinued operations per share - diluted (In dollars per share) 0.01 (0.05)
Net loss per share - basic (in dollar per share) (0.17) (0.1)
Net loss per share - diluted (in dollar per share) $ (0.17) $ (0.21)
Weighted average common shares outstanding - basic (in shares) 42,998,504 38,616,207
Weighted average common shares outstanding - diluted (in shares) 42,998,504 42,913,111